Physician profile
Arman Yaghoubian
NPI 1568788859
$557.62
in general payments reported to CMS, 2019-2025
15 companies · $33.58 in 2025
The $33.58 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.62 · 2020: $40.78 · 2021: $201 · 2022: $58.48 · 2023: $81.21 · 2024: $125 · 2025: $33.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $149.99 | 2021 | |
| Sirtex Medical INC | $43.78 | 2024 | Lava Les (Liquid Embolic System) |
| Cook Medical LLC | $41.58 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $33.83 | 2024 | Microthermx Microwave Ablation System |
| Novartis Pharmaceuticals Corporation | $33.58 | 2025 | |
| Leica Microsystems INC. | $32.02 | 2022 | |
| Laborie Medical Technologies Corp. | $31.71 | 2024 | Alphaone |
| Chiesi USA, INC. | $30.44 | 2021 | |
| Boston Scientific Corporation | $28.89 | 2023 | |
| Myriad Genetic Laboratories, INC. | $27.98 | 2023 | Myrisk |
| Medtronic, INC. | $26.46 | 2022 | |
| Abbott Laboratories | $24.34 | 2023 | Jeti |
| Terumo Medical Corporation | $20.71 | 2021 | |
| Cardiovascular Systems INC. | $16.82 | 2020 | |
| Becton, Dickinson and Company | $15.49 | 2024 | Site-Rite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arman Yaghoubian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.